Cited by 42Wound Healing and TreatmentsDermatologic Treatments and ResearchFacial Rejuvenation and Surgery Techniques

From Polydeoxyribonucleotides (PDRNs) to Polynucleotides (PNs): Bridging the Gap Between Scientific Definitions, Molecular Insights, and Clinical Applications of Multifunctional Biomolecules

Open access
Marques, Cíntia, Porcello, Alexandre, Cerrano, Marco, Hadjab, Farid, Chemali, Michèle, Lourenço, Kelly, Hadjab, Basste, Raffoul, Wassim +2 more·2025·Biomolecules

Abstract

Polydeoxyribonucleotides (PDRNs) and polynucleotides (PNs) are similar DNA-derived biopolymers that have garnered significant scientific attention since the 1990s for their potential applications in wound healing and skin rejuvenation. These biopolymers exhibit a broad molecular weight (MW) range, typically spanning from 50 to 1500 kDa. However, recent studies have expanded this range to encompass fragments as small as 1 kDa and as large as 10,000 kDa. Clinically, PDRN/PN formulations, commercially available in various galenic forms (gels, creams, serums, masks, and injectables), have demonstrated promising effects in significantly promoting skin regeneration, reducing inflammation, improving skin texture, preventing scar formation, and mitigating wrinkles. Importantly, despite their widespread use in cosmetology and aesthetic dermatology, the interchangeable use of the terms “PDRN” and “PN” in the scientific literature (to describe polymers of varying lengths) has led to considerable confusion within the medical and scientific communities. To specifically address this PDRN/PN ambiguity, this narrative review proposes a standardized structure-based nomenclature for these DNA-derived polymers, the “Marques Polynucleotide Cutoff”, set at 1500 kDa. Thus, we propose that the term “PDRN” should be exclusively reserved for small- and medium-chain polymers (MW < 1500 kDa), while the term “PN” should specifically be used to denote longer-chain polymers (MW ≥ 1500 kDa). In a broader perspective, this classification is based on the distinct physicochemical properties and therapeutic effects of these DNA fragments of various MWs, which are comprehensively discussed in the present review.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom15010148

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PDRN is composed of a linear structure of deoxyribonucleotides linked by phosphodiester bonds, which is double stranded.

    “PDRN, similar to PN, is composed of a linear structure of deoxyribonucleotides linked by phosphodiester bonds, which is double stranded [11,23].”

    From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [11]

    The Introduction describes PDRN and PN as DNA fragments composed of deoxyribonucleotide units and measured in base pairs. Section 2 calls them chains of deoxyribonucleotides and describes DNA as a double helix. The copy does not specify that the units are linked by phosphodiester bonds, so that detail is not supported by this source. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Both PN and PDRN are nucleic acid-derived polymers composed of nucleotide monomers connected via phosphodiester bonds.

    “Both PN and PDRN are nucleic acid-derived polymers composed of nucleotide monomers connected via phosphodiester bonds [11,17].”

    From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [11]

    The Introduction and Section 2 describe both PDRN and PN as DNA-derived polymers made of deoxyribonucleotide units. Our copy does not specify that the units are connected by phosphodiester bonds, so that detail is not directly supported by this source. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • PN forms a more porous, highly viscous, three-dimensional structure.

    “However, PDRN exhibits lower viscoelasticity than that of PN because of its reduced molecular weight, whereas PN forms a more porous, highly viscous, three-dimensional structure [11,24,25].”

    From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [11]

    Section 5 says PN is used to make hydrogels with high viscosity. Section 6 describes a scaffolded, polygonal structure in a PN-based hydrogel, but does not establish that it is more porous than PDRN or explicitly characterize that PN structure as three-dimensional. Page numbers are unavailable in our copy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • PDRN exhibits lower viscoelasticity than PN because of its reduced molecular weight.

    “However, PDRN exhibits lower viscoelasticity than that of PN because of its reduced molecular weight, whereas PN forms a more porous, highly viscous, three-dimensional structure [11,24,25].”

    From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [11]

    Section 5 describes PDRN as generally having a lower molecular weight than PN, calls PN viscoelastic, and links PN’s high molecular weight to high-viscosity hydrogels. The Conclusions also say viscosity can vary with the final molecular weight of a formulation. The paper does not directly establish that PDRN is less viscoelastic than PN as a general comparison. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • PDRN has demonstrated a strong safety profile in both acute and chronic toxicity studies, with no significant immunogenic responses.

    “PDRN has demonstrated a strong safety profile in both acute and chronic toxicity studies, where no significant immunogenic responses were observed [11,17,19].”

    From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [11]

    Section 4 (page not available) reports that salmon-derived PDRN/PN has a lower chance of eliciting an immune response and cites studies of its biocompatibility and safety. The paper does not report acute or chronic toxicity-study results or state that those studies observed no significant immunogenic responses. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 78

  1. [1]Rho N.K. Han K.H. Cho M. Kim H.S. A Survey on the Cosmetic Use of Injectable Polynucleotide: The Pattern of Practice Among Korean Dermatologists J. Cos. Dermatol. 2024 23 1243 1252 10.1111/jocd.16125 38093498 · DOI · Paper page
  2. [2]Nguyen T.H. Wang S.-L. Nguyen V.B. Recent Advances on Polydeoxyribonucleotide Extraction and Its Novel Application in Cosmeceuticals Int. J. Biol. Macromol. 2024 282 137051 10.1016/j.ijbiomac.2024.137051 39486723 · DOI · Paper page
  3. [3]Khan A. Wang G. Zhou F. Gong L. Zhang J. Qi L. Cui H. Polydeoxyribonucleotide: A Promising Skin Anti-Aging Agent Chin. J. Plast. Reconstruct. Surg. 2022 4 187 193 10.1016/j.cjprs.2022.09.015 · DOI · Paper page
  4. [4]Kim T.-H. Heo S.-Y. Oh G.-W. Heo S.-J. Jung W.-K. Applications of Marine Organism-Derived Polydeoxyribonucleotide: Its Potential in Biomedical Engineering Marine Drugs 2021 19 296 10.3390/md19060296 34067499 PMC8224764 · DOI · Paper page
  5. [7]Montesinos M.C. Gadangi P. Longaker M. Sung J. Levine J. Nilsen D. Reibman J. Li M. Jiang C.-K. Hirschhorn R. Wound Healing Is Accelerated by Agonists of Adenosine A2 (Gαs-Linked) Receptors J. Exp. Med. 1997 186 1615 1620 10.1084/jem.186.9.1615 9348321 PMC2199104 · DOI
  6. [8]Tonello G. Daglio M. Zaccarelli N. Sottofattori E. Mazzei M. Balbi A. Characterization and Quantitation of the Active Polynucleotide Fraction (PDRN) from Human Placenta, a Tissue Repair Stimulating Agent J. Pharm. Biomed. Anal. 1996 14 1555 1560 10.1016/0731-7085(96)01788-8 8877863 · DOI · Paper page
  7. [9]Squadrito F. Bitto A. Irrera N. Pizzino G. Pallio G. Minutoli L. Altavilla D. Pharmacological Activity and Clinical Use of PDRN Front. Pharmacol. 2017 8 224 10.3389/fphar.2017.00224 28491036 PMC5405115 · DOI · Paper page
  8. [12]Proskurina A. Nikolin V. Popova N. Varaksin N. Ryabicheva T. Ershova E. Kostyuk S. Leplina O. Ostanin A. Chernykh E. Comparing the Biological Properties of Double-Stranded DNA Extracted from Human and Porcine Placenta and Salmon Sperm Rep. Biochem. Mol. Biol. 2023 11 577 10.52547/rbmb.11.4.577 37131888 PMC10149128 · DOI
  9. [17]Bianchini P. Tellini N. Morani A.M. Folloni M.G. Pharmacological Data on Polydeoxyribonucleotide of Human Placenta Int. J. Tissue React. 1981 3 151 154 6460689
  10. [18]Sini P. Denti A. Cattarini G. Daglio M. Tira M.E. Balduini C. Effect of Polydeoxyribonucleotides on Human Fibroblasts in Primary Culture Cell Biochem. Funct. 1999 17 107 114 10.1002/(SICI)1099-0844(199906)17:2<107::AID-CBF815>3.0.CO;2-# 10377956 · DOI
  11. [19]Thellung S. Florio T. Maragliano A. Cattarini G. Schettini G. Polydeoxyribonucleotides Enhance the Proliferation of Human Skin Fibroblasts: Involvement of A2 Purinergic Receptor Subtypes Life Sci. 1999 64 1661 1674 10.1016/S0024-3205(99)00104-6 10328526 · DOI · Paper page
  12. [22]Kim M.J. Park H.-J. Jung R.-J. Won C.-Y. Ohk S.-O. Kim H.-T. Roh N.-K. Yi K.-H. High-Resolution 3-D Scanning Electron Microscopy (SEM) Images of DOTTM Polynucleotides (PN): Unique Scaffold Characteristics and Potential Applications in Biomedicine Skin Res. Technol. 2024 30 e13667 10.1111/srt.13667 38558437 PMC10982675 · DOI · Paper page
  13. [23]Park K.Y. Seok J. Rho N.K. Kim B.J. Kim M.N. Long-Chain Polynucleotide Filler for Skin Rejuvenation: Efficacy and Complications in Five Patients Dermatol. Ther. 2016 29 37 40 10.1111/dth.12299 26814448 · DOI · Paper page
  14. [25]Cavallini M. Bartoletti E. Maioli L. Massirone A. Pia Palmieri I. Papagni M. Priori M. Trocchi G. Consensus Report on the Use of PN-HPTTM (Polynucleotides Highly Purified Technology) in Aesthetic Medicine J. Cosmet. Dermatol. 2021 20 922 928 10.1111/jocd.13679 32799391 PMC7984045 · DOI · Paper page
  15. [26]Valdatta L. Thione A. Mortarino C. Buoro M. Tuinder S. Evaluation of the Efficacy of Polydeoxyribonucleotides in the Healing Process of Autologous Skin Graft Donor Sites: A Pilot Study Curr. Med. Res. Opin. 2004 20 403 408 10.1185/030079904125003116 15025849 · DOI · Paper page
  16. [27]Galeano M. Bitto A. Altavilla D. Minutoli L. Polito F. Calò M. Lo Cascio P. Stagno d’Alcontres F. Squadrito F. Polydeoxyribonucleotide Stimulates Angiogenesis and Wound Healing in the Genetically Diabetic Mouse Wound Rep. Regen. 2008 16 208 217 10.1111/j.1524-475X.2008.00361.x 18318806 · DOI
  17. [28]Gennero L. De Siena R. Denysenko T. Roos M.A. Calisti G.F. Martano M. Fiobellot S. Panzone M. Reguzzi S. Gabetti L. A Novel Composition for in Vitro and in Vivo Regeneration of Skin and Connective Tissues Cell Biochem. Funct. 2011 29 311 333 10.1002/cbf.1751 21491468 · DOI
  18. [29]De Caridi G. Massara M. Acri I. Zavettieri S. Grande R. Butrico L. de Franciscis S. Serra R. Trophic Effects of Polynucleotides and Hyaluronic Acid in the Healing of Venous Ulcers of the Lower Limbs: A Clinical Study Int. Wound J. 2016 13 754 758 10.1111/iwj.12368 25224018 PMC7949893 · DOI
  19. [30]Yu M. Lee J.Y. Polydeoxyribonucleotide Improves Wound Healing of Fractional Laser Resurfacing in Rat Model J. Cosmet. Laser Ther. 2017 19 43 48 10.1080/14764172.2016.1247966 27762652 · DOI · Paper page
  20. [31]Hwang K.-H. Kim J.-H. Park E.Y. Cha S.-K. An Effective Range of Polydeoxyribonucleotides Is Critical for Wound Healing Quality Mol. Med. Rep. 2018 18 5166 5172 10.3892/mmr.2018.9539 30320361 · DOI · Paper page
  21. [32]Colangelo M.T. Belletti S. Govoni P. Guizzardi S. Galli C. A Biomimetic Polynucleotides–Hyaluronic Acid Hydrogel Promotes Wound Healing in a Primary Gingival Fibroblast Model Appl. Sci. 2021 11 4405 10.3390/app11104405 · DOI · Paper page
  22. [33]Kim T.-H. Kim S.-C. Park W.S. Choi I.-W. Kim H.-W. Kang H.W. Kim Y.-M. Jung W.-K. PCL/Gelatin Nanofibers Incorporated with Starfish Polydeoxyribonucleotides for Potential Wound Healing Applications Mat. Design 2023 229 111912 10.1016/j.matdes.2023.111912 · DOI
  23. [34]Suamte L. Tirkey A. Babu P.J. Design of 3D Smart Scaffolds Using Natural, Synthetic and Hybrid Derived Polymers for Skin Regenerative Applications Smart Mat. Med. 2023 4 243 256 10.1016/j.smaim.2022.09.005 · DOI
  24. [35]Lee D. Kim M.J. Park H.J. Rah G.C. Choi H. Anh S.-T. Ji G.H. Kim M.S. Kim G. Shin D.W. Current Practices and Perceived Effectiveness of Polynucleotides for Treatment of Facial Erythema by Cosmetic Physicians Skin Res. Technol. 2023 29 e13466 10.1111/srt.13466 37753681 PMC10485387 · DOI
  25. [36]Veronesi F. Dallari D. Sabbioni G. Carubbi C. Martini L. Fini M. Polydeoxyribonucleotides (PDRNs) From Skin to Musculoskeletal Tissue Regeneration via Adenosine A2A Receptor Involvement J. Cell. Physiol. 2017 232 2299 2307 10.1002/jcp.25663 27791262 · DOI
  26. [37]Perez-Aso M. Mediero A. Cronstein B.N. Adenosine A2A Receptor (A2AR) Is a Fine-Tune Regulator of the Collagen1:Collagen3 Balance Purin. Signal. 2013 9 573 583 10.1007/s11302-013-9368-1 23749290 PMC3889389 · DOI
  27. [38]Shin S.M. Baek E.J. Kim K.H. Kim K.J. Park E.J. Polydeoxyribonucleotide Exerts Opposing Effects on ERK Activity in Human Skin Keratinocytes and Fibroblasts Mol. Med. Rep. 2023 28 148 10.3892/mmr.2023.13035 37350391 PMC10308489 · DOI · Paper page
  28. [39]Kang S.H. Choi M.S. Kim H.K. Kim W.S. Bae T.H. Kim M.K. Chang S.H. Polydeoxyribonucleotide Improves Tendon Healing Following Achilles Tendon Injury in Rats J. Orthop. Res. 2018 36 1767 1776 10.1002/jor.23796 29094396 · DOI
  29. [40]Shin J.-W. Kwon S.-H. Choi J.-Y. Na J.-I. Huh C.-H. Choi H.-R. Park K.-C. Molecular Mechanisms of Dermal Aging and Antiaging Approaches Int. J. Mol. Sci. 2019 20 2126 10.3390/ijms20092126 31036793 PMC6540032 · DOI · Paper page
  30. [41]Fisher G.J. Varani J. Voorhees J.J. Looking Older: Fibroblast Collapse and Therapeutic Implications Arch. Dermatol. 2008 144 666 672 10.1001/archderm.144.5.666 18490597 PMC2887041 · DOI · Paper page
  31. [42]Lee H. Hong Y. Kim M. Structural and Functional Changes and Possible Molecular Mechanisms in Aged Skin Int. J. Mol. Sci. 2021 22 12489 10.3390/ijms222212489 34830368 PMC8624050 · DOI
  32. [43]McLafferty E. Hendry C. Farley A. The Integumentary System: Anatomy, Physiology and Function of Skin Nurs. Stand. 2012 27 35 42 10.7748/ns2012.09.27.3.35.c9299 23248884 · DOI
  33. [44]Raposio E. Guida C. Coradeghini R. Scanarotti C. Parodi A. Baldelli I. Fiocca R. Santi P.L. In Vitro Polydeoxyribonucleotide Effects on Human Pre-Adipocytes Cell Prolif. 2008 41 739 754 10.1111/j.1365-2184.2008.00547.x 18673371 PMC6496018 · DOI
  34. [45]Kim M.J. Park H. Oh S.M. Yi K. Polynucleotide Injection Treatment for Iatrogenic Fat Atrophy in Two Patients: Potential for Safe Volumization in Aesthetic Medicine Skin Res. Technol. 2023 29 e13439 10.1111/srt.13439 37632185 PMC10423761 · DOI · Paper page
  35. [46]Kim Y.-J. Kim M.-J. Kweon D.-K. Lim S.-T. Lee S.-J. Polydeoxyribonucleotide Activates Mitochondrial Biogenesis but Reduces MMP-1 Activity and Melanin Biosynthesis in Cultured Skin Cells Appl. Biochem. Biotechnol. 2020 191 540 554 10.1007/s12010-019-03171-2 31811642 · DOI · Paper page
  36. [47]Kim T.-H. Heo S.-Y. Han J.S. Jung W.-K. Anti-Inflammatory Effect of Polydeoxyribonucleotides (PDRN) Extracted from Red Alga (Porphyra Sp.) (Ps-PDRN) in RAW 264.7 Macrophages Stimulated with Escherichia coli Lipopolysaccharides: A Comparative Study with Commercial PDRN Cell Biochem. Funct. 2023 41 889 897 10.1002/cbf.3840 37589166 · DOI · Paper page
  37. [48]Kuppa S.S. Kim H.-K. Kang J.-Y. Lee S.-C. Yang H.-Y. Sankaranarayanan J. Seon J.-K. Polynucleotides Suppress Inflammation and Stimulate Matrix Synthesis in an In Vitro Cell-Based Osteoarthritis Model Int. J. Mol. Sci. 2023 24 12282 10.3390/ijms241512282 37569659 PMC10418450 · DOI · Paper page
  38. [49]Guizzardi S. Galli C. Govoni P. Boratto R. Cattarini G. Martini D. Belletti S. Scandroglio R. Polydeoxyribonucleotide (PDRN) Promotes Human Osteoblast Proliferation: A New Proposal for Bone Tissue Repair Life Sci. 2003 73 1973 1983 10.1016/S0024-3205(03)00547-2 12899922 · DOI · Paper page
  39. [50]Mazzuco R. Evangelista C. Gobbato D.O. de Almeida L.M. Clinical and Histological Comparative Outcomes after Injections of Poly-L-Lactic Acid and Calcium Hydroxyapatite in Arms: A Split Side Study J. Cosmet. Dermatol. 2022 21 6727 6733 10.1111/jocd.15356 36098704 · DOI
  40. [51]Fitzgerald R. Bass L.M. Goldberg D.J. Graivier M.H. Lorenc Z.P. Physiochemical Characteristics of Poly-L-Lactic Acid (PLLA) Aesthet. Surg. J. 2018 38 S13 S17 10.1093/asj/sjy012 29897517 · DOI
  41. [52]Goldberg D. Guana A. Volk A. Daro-Kaftan E. Single-Arm Study for the Characterization of Human Tissue Response to Injectable Poly-L-Lactic Acid Dermatol. Surg. 2013 39 915 922 10.1111/dsu.12164 23464798 · DOI
  42. [53]Kim J.A. Van Abel D. Neocollagenesis in Human Tissue Injected with a Polycaprolactone-Based Dermal Filler J. Cosmet. Laser Ther. 2015 17 99 101 10.3109/14764172.2014.968586 25260139 · DOI
  43. [54]Christen M.-O. Vercesi F. Polycaprolactone: How a Well-Known and Futuristic Polymer Has Become an Innovative Collagen-Stimulator in Esthetics Clin. Cosmet. Investig. Dermatol. 2020 13 31 48 10.2147/CCID.S229054 PMC7065466 32161484 · DOI
  44. [55]Bohnert K. Dorizas A. Lorenc P. Sadick N.S. Randomized, Controlled, Multicentered, Double-Blind Investigation of Injectable Poly-l-Lactic Acid for Improving Skin Quality Dermatol. Surg. 2019 45 718 10.1097/DSS.0000000000001772 30741790 · DOI
  45. [56]Kadouch J.A. Calcium Hydroxylapatite: A Review on Safety and Complications J. Cosmet. Dermatol. 2017 16 152 161 10.1111/jocd.12326 28247924 · DOI
  46. [57]Zago Sá Fortes R. Cassol Spanemberg J. Cherubini K. Salum F.G. Adverse Events and Satisfaction Outcomes with Calcium Hydroxylapatite and Polycaprolactone Fillers in Facial Aesthetics: A Systematic Review Cosmetics 2024 11 165 10.3390/cosmetics11050165 · DOI
  47. [58]Fitzgerald R. Bertucci V. Sykes J.M. Duplechain J.K. Adverse Reactions to Injectable Fillers Facial Plast. Surg. 2016 32 532 555 10.1055/s-0036-1592340 27680525 · DOI
  48. [59]Palmieri I. Raichi M. Biorevitalization of Postmenopausal Labia Majora, the Polynucleotide/Hyaluronic Acid Option Obstet. Gynecol. Rep. 2019 3 10.15761/OGR.1000135 · DOI
  49. [60]Abdoli R. Zamani P. Ghasemi M. Genetic Similarities and Phylogenetic Analysis of Human and Farm Animal Species Based on Mitogenomic Nucleotide Sequences Meta Gene 2018 15 23 26 10.1016/j.mgene.2017.10.004 · DOI
  50. [61]Vanelli R. Costa P. Rossi S.M.P. Benazzo F. Efficacy of Intra-Articular Polynucleotides in the Treatment of Knee Osteoarthritis: A Randomized, Double-Blind Clinical Trial Knee Surg. Sports Traumatol. Arthrosc. 2010 18 901 907 10.1007/s00167-009-1039-y 20111953 · DOI
  51. [62]Kim M.S. Cho R.K. In Y. The Efficacy and Safety of Polydeoxyribonucleotide for the Treatment of Knee Osteoarthritis Medicine 2019 98 e17386 10.1097/MD.0000000000017386 31574892 PMC6775356 · DOI · Paper page
  52. [63]Shu Z. Ji Y. Liu F. Jing Y. Jiao C. Li Y. Zhao Y. Wang G. Zhang J. Proteomics Analysis of the Protective Effect of Polydeoxyribonucleotide Extracted from Sea Cucumber (Apostichopus japonicus) Sperm in a Hydrogen Peroxide-Induced RAW264.7 Cell Injury Model Marine Drugs 2024 22 325 10.3390/md22070325 39057434 PMC11277713 · DOI · Paper page
  53. [64]Lee K.-S. Lee S. Wang H. Lee G. Kim S. Ryu Y.-H. Chang N.H. Kang Y.-W. Analysis of Skin Regeneration and Barrier-Improvement Efficacy of Polydeoxyribonucleotide Isolated from Panax Ginseng (C.A. Mey.) Adventitious Root Molecules 2023 28 7240 10.3390/molecules28217240 37959659 PMC10649580 · DOI
  54. [65]PharmaResearch, “Rejuran®” Accelerates Entry into Vietnam Available online: https://pharmaresearch.co.kr/en/press/view.html?idx=262 (accessed on 18 November 2024)
  55. [66]PharmaResearch Participates in “IMCAS PARIS 2024” with Rejuran®… Stepping into the European Market in Earnest Available online: https://pharmaresearch.co.kr/en/press/view.html?idx=67&curpage=1 (accessed on 18 November 2024)
  56. [67]Kim J.H. Jeong J.J. Lee Y.I. Lee W.J. Lee C. Chung W.Y. Nam K.-H. Lee J.H. Preventive Effect of Polynucleotide on Post-Thyroidectomy Scars: A Randomized, Double-Blinded, Controlled Trial Lasers Surg. Med. 2018 50 755 762 10.1002/lsm.22812 29574803 · DOI · Paper page
  57. [68]Lee Y.J. Kim H.T. Lee Y.J. Paik S.H. Moon Y.S. Lee W.J. Chang S.E. Lee M.W. Choi J.H. Jung J.M. Comparison of the Effects of Polynucleotide and Hyaluronic Acid Fillers on Periocular Rejuvenation: A Randomized, Double-Blind, Split-Face Trial J. Dermatol. Treat. 2022 33 254 260 10.1080/09546634.2020.1748857 32248707 · DOI
  58. [69]Olariu L. Dumitriu B.G. Gaidau C. Stanca M. Tanase L.M. Ene M.D. Stanculescu I.-R. Tablet C. Bioactive Low Molecular Weight Keratin Hydrolysates for Improving Skin Wound Healing Polymers 2022 14 1125 10.3390/polym14061125 35335455 PMC8955321 · DOI
  59. [70]Gruber J.V. Holtz R. Riemer J. Hyaluronic Acid (HA) Stimulates the in Vitro Expression of CD44 Proteins but Not HAS1 Proteins in Normal Human Epidermal Keratinocytes (NHEKs) and Is HA Molecular Weight Dependent J. Cosmet. Dermatol. 2022 21 1193 1198 10.1111/jocd.14188 33908161 · DOI
  60. [72]Maharjan A.S. Pilling D. Gomer R.H. High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation PLoS ONE 2011 6 e26078 10.1371/journal.pone.0026078 22022512 PMC3191166 · DOI
  61. [73]Lee K.W.A. Chan K.W.L. Lee A. Lee C.H. Wan J. Wong S. Yi K.H. Polynucleotides in Aesthetic Medicine: A Review of Current Practices and Perceived Effectiveness Int. J. Mol. Sci. 2024 25 8224 10.3390/ijms25158224 39125793 PMC11311621 · DOI · Paper page
  62. [74]Scruggs R.L. Achter E.K. Ross P.D. The Thermodynamic Effects of Exposing Nucleic Acid Bases to Water: Solubility Measurements in Water and Organic Solvents Biopolymers 1972 11 1961 1972 10.1002/bip.1972.360110915 5072741 · DOI
  63. [75]Singh A. Bhatia D. Chapter 16—DNA Hydrogels: Principles, Synthesis, Characterization and Applications to Cell Biology Methods in Cell Biology Shukla A.K. Biomolecular Interactions Part B Academic Press Cambridge, MA, USA 2022 Volume 169 323 346 10.1016/bs.mcb.2022.01.002 35623710 · DOI
  64. [76]Liu D. Wyttenbach T. Bowers M.T. Hydration of Mononucleotides J. Am. Chem. Soc. 2006 128 15155 15163 10.1021/ja062418o 17117867 · DOI
  65. [77]Lee S.L. Debenedetti P.G. Errington J.R. Pethica B.A. Moore D.J. A Calorimetric and Spectroscopic Study of DNA at Low Hydration J. Phys. Chem. B 2004 108 3098 3106 10.1021/jp0311409 · DOI
  66. [78]Khesbak H. Savchuk O. Tsushima S. Fahmy K. The Role of Water H-Bond Imbalances in B-DNA Substate Transitions and Peptide Recognition Revealed by Time-Resolved FTIR Spectroscopy J. Am. Chem. Soc. 2011 133 5834 5842 10.1021/ja108863v 21446714 · DOI
  67. [79]Yatsunyk L.A. Neidle S. On Water Arrangements in Right- and Left-Handed DNA Structures Molecules 2024 29 505 10.3390/molecules29020505 38276583 PMC10820154 · DOI
  68. [80]Falk M. A Gravimetric Study of Hydration of Polynucleotides Can. J. Chem. 1966 44 1107 1111 10.1139/v66-167 · DOI
  69. [81]Kim J.H. Kim E.S. Kim S.W. Hong S.P. Kim J. Effects of Polynucleotide Dermal Filler in the Correction of Crow’s Feet Using an Antera Three-Dimensional Camera Aesth. Plast. Surg. 2022 46 1902 1909 10.1007/s00266-022-02832-8 35357558 · DOI · Paper page
  70. [83]Manfredini M. Poli P.P. Beretta M. Pellegrini M. Salina F.E. Maiorana C. Polydeoxyribonucleotides Pre-Clinical Findings in Bone Healing: A Scoping Review Dentist. J. 2023 11 280 10.3390/dj11120280 PMC10743101 38132418 · DOI
  71. [84]Walia S. Morya V. Gangrade A. Naskar S. Guduru Teja A. Dalvi S. Maiti P.K. Ghoroi C. Bhatia D. Designer DNA Hydrogels Stimulate 3D Cell Invasion by Enhanced Receptor Expression and Membrane Endocytosis ACS Biomater. Sci. Eng. 2021 7 5933 5942 10.1021/acsbiomaterials.1c01085 34856099 · DOI
  72. [85]Zhang H. Vandesompele J. Braeckmans K. Smedt S.C.D. Remaut K. Nucleic Acid Degradation as Barrier to Gene Delivery: A Guide to Understand and Overcome Nuclease Activity Chem. Soc. Rev. 2024 53 317 360 10.1039/D3CS00194F 38073448 · DOI
  73. [86]Shao Y. Jia H. Cao T. Liu D. Supramolecular Hydrogels Based on DNA Self-Assembly Acc. Chem. Res. 2017 50 659 668 10.1021/acs.accounts.6b00524 28299927 · DOI
  74. [87]Burdick J.A. Murphy W.L. Moving from Static to Dynamic Complexity in Hydrogel Design Nat. Commun. 2012 3 1269 10.1038/ncomms2271 23232399 · DOI
  75. [88]Quan T. Wang F. Shao Y. Rittié L. Xia W. Orringer J.S. Voorhees J.J. Fisher G.J. Enhancing Structural Support of the Dermal Microenvironment Activates Fibroblasts, Endothelial Cells and Keratinocytes in Aged Human Skin in Vivo J. Investig. Dermatol. 2013 133 658 667 10.1038/jid.2012.364 23096713 PMC3566280 · DOI
  76. [89]Ayatollahi A. Firooz A. Samadi A. Evaluation of Safety and Efficacy of Booster Injections of Hyaluronic Acid in Improving the Facial Skin Quality J. Cosmet. Dermatol. 2020 19 2267 2272 10.1111/jocd.13493 32419355 · DOI
  77. [90]Papakonstantinou E. Roth M. Karakiulakis G. Hyaluronic Acid: A Key Molecule in Skin Aging Dermato-Endocrinol. 2012 4 253 258 10.4161/derm.21923 23467280 PMC3583886 · DOI · Paper page
  78. [91]Witting M. Boreham A. Brodwolf R. Vávrová K. Alexiev U. Friess W. Hedtrich S. Interactions of Hyaluronic Acid with the Skin and Implications for the Dermal Delivery of Biomacromolecules Mol. Pharm. 2015 12 1391 1401 10.1021/mp500676e 25871518 · DOI

Cited by

Sorted by citations

Authors
Marques, C., Porcello, A., Cerrano, M., Hadjab, F., Chemali, M., Lourenço, K., Hadjab, B., Raffoul, W., Applegate, L. A., & Laurent, A. E.
Affiliations
  • Development Department, LOUNA REGENERATIVE SA, CH-1207 Geneva, Switzerland
  • Aesthetic Surgery Department, Clinique Entourage, CH-1003 Lausanne, Switzerland
  • Development Department, Albomed GmbH, D-90592 Schwarzenbruck, Germany
  • Plastic and Aesthetic Surgery Service, Centre Médical Lausanne Ouest, CH-1008 Prilly, Switzerland
  • Independent Consultant Office, F-74330 Poisy, France
  • Hôpital de Morges (CH)
  • University of Zurich (CH)
  • Centre Hospitalier Universitaire Vaudois (CH)
Corresponding author
Laurent, Alexis E.
Venue
Biomolecules
Publisher
MDPI AG
Published
2025-01-19
Volume
15
Issue
1
Pages
148
ISSN
2218-273X (ISSN-L)
OpenAlex
W4406629001
Cited by
42
References
2
Citations by year
2026: 22 · 2025: 20
FWCI
4.90
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (acceptedVersion, cc-by)
  • IRIS (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
  • Health Sciences › Medicine › Dermatology › Facial Rejuvenation and Surgery Techniques
Keywords
polydeoxyribonucleotide, polynucleotides, molecular weight cut-off, terminology standardization, skin regeneration, wound healing, scar prevention, wrinkle reduction, anti-aging cosmetics, cosmetic dermatology, inflammation reduction, skin texture
MeSH terms
Animals, Humans, Molecular Weight, Polydeoxyribonucleotides, Polynucleotides, Wound Healing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review